Geneos Wealth Management’s Brookfield BN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $935K | Sell |
23,107
-382
| -2% | -$16.9K | 0.02% | 523 |
|
|
2025
Q4 | $1.08M | Buy |
23,489
+747
| +3% | +$34.1K | 0.03% | 484 |
|
|
2025
Q3 | $1.04M | Sell |
22,742
-21
| -0.1% | -$930 | 0.03% | 478 |
|
|
2025
Q2 | $939K | Sell |
22,763
-23,760
| -51% | -$880K | 0.02% | 550 |
|
|
2025
Q1 | $1.63M | Buy |
46,523
+23,958
| +106% | +$906K | 0.02% | 537 |
|
|
2024
Q4 | $864K | Buy |
+22,565
| New | +$850K | 0.03% | 452 |
|
|
2022
Q4 | – | Sell |
-13,929
| Closed | -$306K | – | 2029 |
|
|
2022
Q3 | $306K | Sell |
13,929
-10,074
| -42% | -$261K | 0.02% | 497 |
|
|
2022
Q2 | $582K | Sell |
24,003
-31
| -0.1% | -$828 | 0.03% | 459 |
|
|
2022
Q1 | $732K | Sell |
24,034
-30
| -0.1% | -$897 | 0.03% | 445 |
|
|
2021
Q4 | $783K | Sell |
24,064
-1,726
| -7% | -$54.6K | 0.03% | 463 |
|
|
2021
Q3 | $759K | Buy |
25,790
+1,732
| +7% | +$50.6K | 0.03% | 463 |
|
|
2021
Q2 | $665K | Sell |
24,058
-169
| -0.7% | -$4.33K | 0.03% | 481 |
|
|
2021
Q1 | $591K | Hold |
24,227
| – | – | 0.02% | 592 |
|
|
2020
Q4 | $584K | Sell |
24,227
-2,760
| -10% | -$55.2K | 0.02% | 498 |
|
|
2020
Q3 | $469K | Buy |
26,987
+682
| +3% | +$12.2K | 0.02% | 446 |
|
|
2020
Q2 | $457K | Sell |
26,305
-1,296
| -5% | -$22.8K | 0.03% | 432 |
|
|
2020
Q1 | $416K | Sell |
27,601
-1,374
| -5% | -$28.3K | 0.03% | 409 |
|
|
2019
Q4 | $600K | Buy |
28,975
+31
| +0.1% | +$618 | 0.03% | 404 |
|
|
2019
Q3 | $557K | Buy |
28,944
+3,249
| +13% | +$58.8K | 0.03% | 388 |
|
|
2019
Q2 | $438K | Buy |
25,695
+33
| +0.1% | +$558 | 0.03% | 438 |
|
|
2019
Q1 | $427K | Buy |
25,662
+42
| +0.2% | +$654 | 0.03% | 439 |
|
|
2018
Q4 | $347K | Buy |
25,620
+37
| +0.1% | +$552 | 0.03% | 455 |
|
|
2018
Q3 | $406K | Buy |
25,583
+527
| +2% | +$8.01K | 0.03% | 431 |
|
|
2018
Q2 | $362K | Buy |
25,056
+42
| +0.2% | +$600 | 0.03% | 392 |
|
|
2018
Q1 | $348K | Sell |
25,014
-457
| -2% | -$6.62K | 0.03% | 385 |
|
|
2017
Q4 | $395K | Sell |
25,471
-771
| -3% | -$11.6K | 0.04% | 362 |
|
|
2017
Q3 | $386K | Buy |
26,242
+36
| +0.1% | +$505 | 0.04% | 352 |
|
|
2017
Q2 | $366K | Buy |
26,206
+2,142
| +9% | +$28.8K | 0.04% | 352 |
|
|
2017
Q1 | $313K | Buy |
24,064
+45
| +0.2% | +$570 | 0.03% | 380 |
|
|
2016
Q4 | $282K | Buy |
24,019
+955
| +4% | +$11.6K | 0.04% | 379 |
|
|
2016
Q3 | $289K | Buy |
23,064
+623
| +3% | +$7.63K | 0.04% | 366 |
|
|
2016
Q2 | $266K | Buy |
22,441
+181
| +0.8% | +$2.17K | 0.04% | 378 |
|
|
2016
Q1 | $270K | Buy |
+22,260
| New | +$240K | 0.04% | 362 |
|
Other funds holding BN
PVI
VCM
PSCM
BC
Geneos Wealth Management's BN Position: Q1 2026 in Review
Geneos Wealth Management reduced its Brookfield (BN) stake by 1.6% in Q1 2026, selling an estimated $16.9K and leaving 23,107 shares worth $935K. The position accounts for 0.02% of the portfolio, ranked #523.
Geneos Wealth Management first reported a position in BN in Q1 2016 and has held it in 33 quarters since. The position peaked at $1.63M in Q1 2025. 914 funds tracked by Wall St. Rank hold BN as of Q1 2026.
- Geneos Wealth Management held 23,107 shares of Brookfield worth $935K as of Q1 2026.
- Geneos Wealth Management sold 382 Brookfield shares in Q1 2026, an estimated $16.9K.
- Brookfield made up 0.02% of Geneos Wealth Management's portfolio in Q1 2026, its #523 holding.
- Geneos Wealth Management first reported a position in Brookfield in Q1 2016 and has held it in 33 quarters since.
- Geneos Wealth Management's Brookfield position peaked at $1.63M in Q1 2025.
- 914 funds tracked by Wall St. Rank held Brookfield as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.